Endovascular stenting in femoropopliteal arteries

Affiliations

¹ Deutsches Herzzentrum München, Technische Universität München, Munich 80636, Germany.
² Deutsches Herzzentrum München, Technische Universität München, Munich 80636, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. Electronic address: byrne@dhm.mhn.de.

Comment

Salvatore Cassese et al. Lancet. 2018.

. 2018 Oct 27;392(10157):1491-1493.

doi: 10.1016/S0140-6736(18)32339-0. Epub 2018 Sep 24.

¹ Deutsches Herzzentrum München, Technische Universität München, Munich 80636, Germany.
² Deutsches Herzzentrum München, Technische Universität München, Munich 80636, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. Electronic address: byrne@dhm.mhn.de.

No abstract available

Comment on

A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.
Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Müller-Hülsbeck S; IMPERIAL investigators. Gray WA, et al. Lancet. 2018 Oct 27;392(10157):1541-1551. doi: 10.1016/S0140-6736(18)32262-1. Epub 2018 Sep 24. Lancet. 2018. PMID: 30262332 Clinical Trial.